Bioresorbable
scaffolds are naturally dissolving devices which are innovated from traditional
scaffolds. It is also known as naturally dissolving stentsor bioresorbable
stents. These devices are used for prevention or treatment of blockage in blood
vessels. Some of the other benefits are includes the better patient outcomes,
greater patient compliance, ability of treatment to encourage blood vessels to
regain vasomotor functionality and lesser requirements for anti-platelet
therapy & administration of anti-thrombotic drugs.
According
to study, “Global
Bioresorbable Scaffolds Market 2019 by Manufacturers, Regions, Type and
Application, Forecast to 2024” some of the major factors which are
currently working in the global bioresorbable scaffolds market are
AbbottVascular, REVA Medical Inc., Kyoto Medical Planning Co. Ltd., B. Braun,
Xenogenics Corp., Amaranth Medical, Inc., Meril Life Sciences Pvt. Ltd.,
Arterial Remodeling Technologies,LEPU medical technology co., ltd., Arterius
Limited, Boston Scientific Corporation, Elixir Medical Corp.,480 Biomedical,
ORBUSNEICH, Qualimed, S3V Vascular Technologies Private Limited, Biotronik.
International players are progressively expanding their footprint in developing
economy, making it complicated for regional vendors to compete with them,
especially for instance product differentiation, quality, product portfolios,
and pricing.
Based
on type, global bioresorbable scaffolds market is segmented into polymer based
bioresorbable scaffolds and metal base bioresorbable scaffolds. Metal base
bioresorbable scaffolds include iron, zinc, magnesium, and their alloys. Based
on material, market is bifurcated into absorbable magnesium stent (AMS), poly
carbonate scaffold, polymeric scaffold and others. Based on devices type,
market is classified as drug eluting coronary scaffolds, sirolimus-eluting
device, everolimus-eluting device, novolimus-eluting device and
paclitaxel-eluting device. Based on absorption rate, market is breakdown into
slow absorption rate and fast absorption rate. Based on application, market is segmented
into regulation of blood flow, peripheral vascular intervention and others. In
addition, based on end-users, market is defined as clinics, hospitals, medical
center and others.
The
global bioresorbable scaffolds market is driven by increase in prevalence of
cardiovascular disease & diabetes, followed by rapid development in devices
used for the cardiovascular surgeries, highly unhealthy lifestyles choices for
instance poor diet and sedentary lifestyles adoption of desk-bound lifestyle,
rising demand for bioresorbable scaffolds and government support for the
research and development (R&D) of better medical devices. However, high
cost of the bioresorbable scaffolds and availability of alternative therapies
that are expected to restrain the market growth.
The
global bioresorbable scaffolds market is dominated by North-American region due
to presence of number of leading companies, and presence of large population
suffering from cardiovascular diseases, with the increased geriatric
population. Moreover, increase in obese & diabetic population, increasing
stress,lack of exercise and desk-bound lifestyle has further provided thrust to
the growth of market followed by North-America, Europe to remain the other key
market owing to increase in government support and availability of huge
research funds. Furthermore, Asia Pacific region accounted for substantial
growth of market owing to increase in healthcare industry, rapid development in
technology, and huge patient sufferings. On the other hand, the Middle East
& Africa holds least share in caused by the presence of poor economies
within the African region.In 2019, value of global bioresorbable scaffolds
market is expected to reach at US $140 million and is estimated to reach at US
$370 million, by 2024.
To
know more, click on the link below:-
Related
Reports:-
Contact
Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment